Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group. - Staiger, A. M.; Ziepert, M.; Horn, H.; Scott, D. W.; Barth, T. F. E.; Bernd, H. W.; Feller, A. C.; Klapper, W.; Szczepanowski, M.; Hummel, M.; Stein, H.; Lenze, D.; et al. (J Clin Oncol, 2017)